Position in GERN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$370,590
+$21,481 QoQ
Shares Held
289,524
+9.5% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 258 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,124 across 425 Biotechnology names. GERN ranks #208 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in GERN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $370,590 | 289,524 | Shares | Defined | 2026-08-12 | |
| 2025-12-31 | $349,109 | 264,478 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $667,530 | 487,249 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $761,523 | 540,088 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $859,868 | 540,799 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $1,765,501 | 498,730 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $2,359,318 | 519,674 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $3,674,764 | 866,690 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $6,599,068 | 1,999,718 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $3,668,390 | 1,738,574 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $3,453,873 | 1,629,186 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,386,131 | 1,677,923 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $517,901 | 214,009 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $525,921 | 224,753 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $327,940 | 211,575 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $261,425 | 192,225 | Shares | Defined | 2022-05-11 | |
| 2021-09-30 | $188,739 | 137,767 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $184,849 | 131,100 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $171,223 | 108,370 | Shares | Defined | 2021-05-12 | |
| 2020-09-30 | $186,352 | 107,099 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $136,092 | 62,428 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $72,346 | 60,795 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||